This mechanism, in conjunction with the complex crosstalk between NF-κB, HIF-1α, and VEGF, underscores the intricate interplay between inflammation, hypoxia, and vascular remodeling in the pathophysiology of COVID-19. This evidence concerns the gene VEGFA and COVID-19.